Myth: "FDA Registered" Means the Same Thing as "FDA Approved"

What this article covers
- The Myth
- " Many prospective patients reasonably assume "registered" is simply a lower-key synonym for "approved" — a box the FDA checked after some kind of review.
- Where the Confusion Comes From
- The vocabulary overlap is the whole problem: both phrases contain the word "FDA," and both sound like official clearance. In reality they refer to two entirely different legal processes — one administrative, one evidentiary — and the agency has had to publish consumer guidance specifically because so many clinics lean on this ambiguity.
- What "FDA Registered" Actually Means
- S. facility that manufactures human cells, tissues, or cellular/tissue-based products (HCT/Ps) regulated solely under section 361 of the Public Health Service Act must register with the FDA and list its products — generally within five days of starting operations, with an annual update every December.
- What Actual FDA Approval Requires
- Approval (via a Biologics License Application, the "351" pathway) means a sponsor submitted controlled clinical trial data showing a specific product, for a specific use and dose, is safe and effective — a process that typically takes years and multiple trial phases. This pathway is real and it works: the FDA has approved cord-blood-derived hematopoietic stem cell products (such as Hemacord) for disorders of blood production, after exactly this kind of rigorous review.
- The Nuanced Reality
- Registration tells you a facility filed paperwork; approval tells you a specific product cleared a rigorous evidentiary bar for a specific condition. A registration number on a homepage says nothing about whether the treatment being sold has been shown to work for what you have.
A striking number of stem cell clinic websites display the phrase "FDA registered" near photos of clean labs and reassuring statistics, trading on the assumption that the word "FDA" alone signals federal safety and efficacy review. It doesn't — and the FDA itself has said so explicitly. This article explains the real, narrow meaning of registration, contrasts it with what actual FDA approval requires, and shows what happens when patients and marketers blur the two.
The Myth
The claim, stated or implied: "This clinic's stem cell product is FDA registered, so it's been vetted by federal regulators the same way an approved drug has." Many prospective patients reasonably assume "registered" is simply a lower-key synonym for "approved" — a box the FDA checked after some kind of review.
Where the Confusion Comes From
The vocabulary overlap is the whole problem: both phrases contain the word "FDA," and both sound like official clearance. In reality they refer to two entirely different legal processes — one administrative, one evidentiary — and the agency has had to publish consumer guidance specifically because so many clinics lean on this ambiguity.
What "FDA Registered" Actually Means
Under 21 CFR Part 1271, any U.S. facility that manufactures human cells, tissues, or cellular/tissue-based products (HCT/Ps) regulated solely under section 361 of the Public Health Service Act must register with the FDA and list its products — generally within five days of starting operations, with an annual update every December. This is a tracking mechanism, not a safety review. The FDA's own registration page states this directly: registration "does not constitute a determination that an establishment is in compliance with applicable rules and regulations... or that the HCT/P is licensed or approved by FDA."
What Actual FDA Approval Requires
Approval (via a Biologics License Application, the "351" pathway) means a sponsor submitted controlled clinical trial data showing a specific product, for a specific use and dose, is safe and effective — a process that typically takes years and multiple trial phases. This pathway is real and it works: the FDA has approved cord-blood-derived hematopoietic stem cell products (such as Hemacord) for disorders of blood production, after exactly this kind of rigorous review. That's the genuine success story inside an otherwise murky landscape — but it's also narrow. It covers blood-forming cell transplants, not the orthopedic, neurological, autoimmune, or anti-aging claims most direct-to-consumer clinics advertise.
What the Evidence Shows About the Gap
- The FDA's current consumer guidance is blunt: clinics sometimes point to registration, product listing, or even a ClinicalTrials.gov entry to suggest legitimacy, but "this does not mean the product is legally marketed." The agency adds that if you're charged money for a stem cell or exosome product outside an FDA-regulated clinical trial, "you are likely being deceived and offered a product illegally" — regardless of any registration status cited.
- This isn't a hypothetical risk. A peer-reviewed 2016 study in Cell Stem Cell by Leigh Turner and Paul Knoepfler identified at least 351 U.S. businesses operating 570 clinics marketing direct-to-consumer stem cell interventions for dozens of conditions — the vast majority without FDA-approved products backing those specific uses. Independent reporting at the time corroborated the same clinic count.
- The FDA's Consumer Alert on Regenerative Medicine Products states plainly that "generally, all stem cell products require FDA approval," and that the only currently approved stem cell products are those cord-blood-derived cells for blood disorders — nothing else.
The Nuanced Reality
Registration tells you a facility filed paperwork; approval tells you a specific product cleared a rigorous evidentiary bar for a specific condition. A registration number on a homepage says nothing about whether the treatment being sold has been shown to work for what you have. The responsible question to ask a clinic isn't "are you FDA registered?" — nearly anyone can be — but "is this specific product FDA-approved for my specific condition, and if not, under what legal authority is it being offered?" A clear, direct answer is a good sign; evasive redirection back to "FDA registered" language is itself diagnostic.
Bottom Line
"FDA registered" and "FDA approved" are not interchangeable, and the FDA's own published guidance says so in plain language: registration is a basic administrative filing, while approval reflects years of controlled clinical evidence for a specific product and use. Hundreds of U.S. clinics have been documented leaning on this exact confusion to market unapproved stem cell treatments. The approved pathway does exist and does real, documented good for the conditions it covers — which is precisely why it's worth knowing when a product falls outside it.
Key Questions Answered
- Does "FDA registered" mean a stem cell product is FDA approved?
- No. Registration under 21 CFR Part 1271 is an administrative filing; the FDA states it is not a determination of compliance or that the product is licensed or approved.
- What does FDA approval of a stem cell product require?
- A Biologics License Application with controlled clinical trial data showing a specific product is safe and effective for a specific use, typically taking years.
- Which stem cell products are FDA approved?
- Per the FDA's consumer alert, only cord-blood-derived hematopoietic stem cell products, such as Hemacord, for disorders of blood production.
Sources
- Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes, U.S. Food and Drug Administration, 2025 — https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes
- Important Patient and Consumer Information About Regenerative Medicine Therapies, U.S. Food and Drug Administration — https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies
- Tissue Establishment Registration, U.S. FDA Center for Biologics Evaluation and Research — https://www.fda.gov/vaccines-blood-biologics/biologics-establishment-registration/tissue-establishment-registration
- Turner L, Knoepfler P. "Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry." Cell Stem Cell, 2016 — https://pubmed.ncbi.nlm.nih.gov/27374789/
- "New paper with Leigh Turner shows huge American stem cell clinic industry: 570 locations," The Niche (Paul Knoepfler), 2016 — https://ipscell.com/2016/06/new-paper-shows-huge-american-stem-cell-clinic-industry-570-locations/
Related Articles
- Fundamentals
What Is Angiogenesis, and Why Does It Matter for Stem Cell Therapy?
New blood vessels don't just show up — they're built, through a process called angiogenesis. Here's what it is, why the body depends on it for healing, and why so much stem cell research is focused on helping it along.
- Fundamentals
Myth: If a Treatment Is Listed on ClinicalTrials.gov, It Must Be Safe and Effective
Seeing a treatment listed on ClinicalTrials.gov can feel like a stamp of approval — but registering a trial costs nothing, requires no proof the treatment works, and isn't vetted by the government for safety or scientific quality.
- Fundamentals
What Are Organoids, and How Are They Grown From Stem Cells?
Organoids are tiny, self-organizing models grown from stem cells. They help study human biology and drug responses but are not complete transplant-ready organs.